|

French Hypertrophic Cardiomyopathy Observatory

RECRUITINGSponsored by French Cardiology Society
Actively Recruiting
SponsorFrench Cardiology Society
Started2010-01
Est. completion2023-12
Eligibility
Age15 Years+
Healthy vol.Accepted
View on ClinicalTrials.gov →

NCT01091480

Summary

Hypertrophic cardiomyopathy (Hypertrophic CardioMyopathy=HCM) remains a poorly understood disease with an assumption insufficiently codified. There is no data available in France on the profile of patients, diagnostic methods and assessment and therapeutic use. The purpose of this study is to establish a monitoring of patients with HCM (sarcomere of origin or not) in France (diagnosis, treatment)

Eligibility

Age: 15 Years+Healthy volunteers accepted
Inclusion Criteria:

* Age ≥ 15 years old
* Patient with HCM defined by an ultrasound thickness of the left ventricle ≥ 13 mm if familial or ≥ 15 mm if sporadic

Exclusion Criteria:

* Expressed refusal to participate in the study
* Significant aortic stenosis (\<1 cm ²)

Conditions2

Heart DiseaseHypertrophic Cardiomyopathy

Browse More Trials

Heart Disease trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.